Clinical Trials
All Clinical Trials - Page 6 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07195994N/ARecruiting
A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
Semaglutide
- NCT07340827Phase 3Recruiting
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Gonadorelin
- NCT07417631N/ACompleted
Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
Dulaglutide
- NCT07437547Phase 2Recruiting
BPC 157 for Acute Hamstring Muscle Strain Repair
BPC-157
- NCT07481747Phase 3Recruiting
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
Tirzepatide
- NCT05689372N/AEnrolling By Invitation
Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Semaglutide
- NCT07437586Phase 2Recruiting
Topical GHK-Cu Gel for Acute Skin Wound Healing
GHK-Cu
- NCT07505745Phase 2Recruiting
MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity
MOTS-c
- NCT07481734Phase 2Recruiting
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
Tesamorelin
- NCT07437560Phase 2Recruiting
Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo
Melanotan-Ii
- NCT07176663N/ANot Yet Recruiting
Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure
Tirzepatide
- NCT07294950Phase 3Recruiting
Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination
Semaglutide
- NCT07323134N/ANot Yet Recruiting
The Effect of Semaglutide on the Intestinal Flora in Obesity
Semaglutide
- NCT06222437Phase 1Withdrawn
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
Semaglutide
- NCT07340788N/ANot Yet Recruiting
Amylin-Induced Migraine Attacks Without Aura
Pramlintide
- NCT07340775N/ANot Yet Recruiting
Hypersensitivity to Amylin in Post-Traumatic Headache
Pramlintide
- NCT06651177Phase 2Recruiting
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Tirzepatide
- NCT07382388N/ANot Yet Recruiting
A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis
Tirzepatide
- NCT07417618N/ACompleted
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
Tirzepatide
- NCT07398222N/ARecruiting
Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study
Tirzepatide
- NCT07357415Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
Retatrutide
- NCT07390110N/AActive Not Recruiting
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
Semaglutide
- NCT07354880Phase 4Not Yet Recruiting
Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease
Tirzepatide
- NCT07619495N/ACompleted
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk
Semaglutide
- NCT07347080EARLY_Phase 1Recruiting
A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT07242534Phase 4Recruiting
Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.
Semaglutide
- NCT07292519Phase 2Not Yet Recruiting
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
Tirzepatide
- NCT07227948Phase 2Recruiting
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Semaglutide
- NCT07401992Phase 4Recruiting
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Semaglutide
- NCT07040592Phase 2Recruiting
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
Semaglutide
- NCT07299084Phase 1Active Not Recruiting
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
Tirzepatide
- NCT07253285Phase 3Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Semaglutide
- NCT07111247Phase 4Recruiting
Insights in Endocervical Mucus Secretion
Gonadorelin
- NCT07640139N/AEnrolling By Invitation
Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
Tirzepatide
- NCT07423247Phase 4Recruiting
Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
Tirzepatide
- NCT07103395Phase 2Recruiting
A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
Thymosin-Alpha-1
- NCT07102056N/ANot Yet Recruiting
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
Octreotide
- NCT07364175N/ARecruiting
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults
Tirzepatide
- NCT07373834N/ARecruiting
Tirzepatide and Muscle Outcomes in Obesity
Tirzepatide
- NCT07187856Phase 2Not Yet Recruiting
Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus
Semaglutide
- NCT05714683N/ANot Yet Recruiting
Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Semaglutide
- NCT07284979Phase 3Recruiting
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Semaglutide
- NCT07295223Phase 3Recruiting
Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
Semaglutide
- NCT07280754N/ANot Yet Recruiting
Evaluation of 25(OH)D3 and LL-37 Levels in Periimplant Sulcus Fluid
Ll-37
- NCT07319975N/ANot Yet Recruiting
Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity
Tirzepatide
- NCT07313813Phase 1Completed
A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT07255209Phase 3Recruiting
A Study of IBI362 in Chinese Adolescents With Obesity or Overweight
Mazdutide
- NCT07225686Phase 3Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
Maridebart-Cafraglutide
- NCT07058155Phase 4Recruiting
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
Tirzepatide
- NCT07282041Phase 2/Phase 3Recruiting
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
Dulaglutide